Fbxo16 could therefore acts as the substrate-recognizing receptor for several proteins involved in cell proliferation, including β-catenin, hnRNPL and NF-κB p65, promotes their degradation and prevents cancer progression (46–48). The gene discussed is FBXO16; the disease is cancer.